The invention relates to a microfluidic device, method, and use for the continuous,
label-free isolation of motile, morphologically normal spermatozoa from
semen samples This invention offers a gentle, reliable, and efficient platform for
sperm selection, serving as an alternative to
centrifugation-based techniques in ART laboratories. By maintaining the structural and genetic integrity of
sperm, it improves fertilization success,
embryo quality, and
pregnancy outcomes. The platform also reduces variability between technicians and limits
exposure to
reactive oxygen species (ROS), ensuring consistent
clinical performance. Beyond its application in
fertility treatments, the
system can be used as a diagnostic tool to assess
sperm motility disorders, susceptibility to
oxidative stress, and
DNA fragmentation dynamics under different environmental conditions or
drug exposures.